Evaluate Safety and Efficacy of an OC Preparation vs Placebo for 6 Treatment Cycles in Women With Moderate Acne.

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2003
The objectives of this study were to evaluate the efficacy and safety of drospirenone 3 mg/ethinyl estradiol 0.02 mg (DRSP/EE) in comparison with placebo in female subjects with moderate acne vulgaris during 6 treatment cycles.
Epistemonikos ID: ad02e3bc3a525caf026f491bfbb1fe2d723e42c4
First added on: May 04, 2024